We protect your health through science

Investigation

Serology

Research Lines

Content with Investigacion Referencia e Investigación en Helmintos .

Referencia e Investigación en Helmintos

null

Research projects

Content with Investigacion Referencia e Investigación en Helmintos .

PROYECTOS VIGENTES

Título del proyecto: "Vesículas extracelulares y otras moléculas de parásitos para el tratamiento de la enfermedad inflamatoria intestinal: PARATREAT-IBD"

Referencia: Proyecto PID2022-137661OB-I00 (MPY 341/23) financiado por MCIN/AEI /10.13039/501100011033/ y por FEDER Una manera de hacer Europa
Fecha Inicio:    01/12/2023
Fecha Fin:    31/08/2026
Financiación: 162.500 Euros
Investigador principal: Javier Sotillo
Agencia Financiadora: Agencia Estatal de Investigación. MICINN.


 

Título del proyecto: "Desarrollo de nuevos métodos diagnósticos y de seguimiento de la infección por schistosoma haematobium"

Referencia: PI23CIII00034 / MPY 386/23
Fecha Inicio:    01/01/2024
Fecha Fin:    31/12/2026
Financiación: 131.500 Euros
Investigador principal: Javier Sotillo
Agencia Financiadora: Instituto de Salud Carlos III (ISCIII/AESI)

 

Título del proyecto: "Desarrollo de herramientas para el control de la teniosis / cisticercosis en zonas endémicas y vigilancia de las helmintosis humanas emergentes en España"

Referencia: PI22CIII/00010
Fecha Inicio: 01/01/2023
Fecha Fin: 31/12/2025
Financiación: 80.000 Euros
Investigador principal: María Jesús Perteguer
Agencia Financiadora: Instituto de Salud Carlos III (ISCIII/AESI)

 

 

PROYECTOS PASADOS

Título del proyecto: "PERITAS: Molecular epidemiological studies on pathways of transmission and longlasting capacity building to prevent cystic echinococcosis infection."
Coordinador: Adriano Casulli. IP of ISCIII: Maria J. Perteguer.
Entidad financiadora: EULAC Health JOINT CALL on Research and Innovation 016-2017
Periodo: 01/03/2019-31/12/2022.
Cuantía total: 1.083.580 €.

Título del proyecto: "Producción de antígenos y controles positivos recombinantes para el desarrollo y la estandarización de nuevos ensayos serológicos aplicados al diagnóstico y control de helmintosis olvidadas. "
Investigador principal: María Jesús Perteguer.
Entidad financiadora: ISCIII-AESI. Instituto de Salud Carlos III
Periodo: 02/11/2018 - 31/06/2022.
Cuantía total: 78.050 €.

Título del proyecto: "Diagnóstico serológico diferencial de helmintiasis asociadas a eosinofilia: desarrollo de ensayos multianalito (xMAP) con antígenos recombinantes de especies de interés clínico"
Investigador principal: María Jesús Perteguer.
Entidad financiadora: ISCIII-AESI. Instituto de Salud Carlos III
Periodo: 01/01/2015 - 31/12/2018 .
Cuantía total: 91.000 €.

Publications

Sort
Category

Vaccination with LytA, LytC, or Pce of Streptococcus pneumoniae Protects against Sepsis by Inducing IgGs That Activate the Complement System

Corsini B, Aguinagalde L, Ruiz S, Domenech M, Yuste J. Vaccination with LytA, LytC, or Pce of Streptococcus pneumoniae Protects against Sepsis by Inducing IgGs That Activate the Complement System. Vaccines. 2021 Feb 23;9(2):186.

PUBMED DOI

Physiologic and transcriptomic effects triggered by overexpression of wild type and mutant DNA topoisomerase I in Streptococcus pneumoniae

García-López M, Hernández P, Megias D, Ferrándiz MJ, de la Campa AG. Int J Mol Sci. 2023; 24:15800.

PUBMED DOI

StaR Is a positive regulator of topoisomerase I activity involved in supercoiling maintenance in Streptococcus pneumoniae

de Vasconcelos Junior AA, Tirado-Vélez JM, Martín-Galiano AJ, Megias D, Ferrándiz MJ, Hernández P, Amblar M, de la Campa AG. Int J Mol Sci. 2023; 24:5973.

PUBMED DOI

Role of PatAB transporter in efflux of levofloxacin in Streptococcus pneumoniae

Amblar M, Zaballos A, de la Campa AG. Antibiotics. 2022; 17:1837.

PUBMED DOI

Content with Investigacion Referencia e Investigación en Helmintos .

List of staff

Additional Information

The main objective of the Serology Laboratory is to provide services to centers of the National Health System, through the offer in the service portfolio of the National Microbiology Center, in carrying out diagnosis and reference through the detection of antibodies, both for primary diagnosis and for reference activities.

For this, it has the appropriate serological methodologies, many of them accredited by ENAC in accordance with the ISO15189 standard. Conducts test validation studies through collaboration agreements with private entities.

Participates in seroprevalence studies, carried out through management assignments with the Ministry of Health and with the Public Health authorities of different autonomous communities.

On the other hand, it participates in research projects in relation to infectious diseases, in recent years on neurological diseases, on emerging diseases and on the viruses included in the MMR vaccine.

The main objective of the Serology Laboratory is to provide services to centers of the National Health System, through the offer in the service portfolio of the National Microbiology Center, in carrying out diagnosis and reference through the detection of antibodies, both for primary diagnosis and for reference activities.

For this, it has the appropriate serological methodologies, many of them accredited by ENAC in accordance with the ISO15189 standard. Conducts test validation studies through collaboration agreements with private entities.

Participates in seroprevalence studies, carried out through management assignments with the Ministry of Health and with the Public Health authorities of different autonomous communities.

On the other hand, it participates in research projects in relation to infectious diseases, in recent years on neurological diseases, on emerging diseases and on the viruses included in the MMR vaccine.

Content with Investigacion Referencia e Investigación en Helmintos .